PATENT CLAIM ANALYSIS

Application Number: 16227132
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["544", "283000"]

Abstract:
The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.

Claim (Index 2):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein W is CR W ; X is CR X ; Y is CR Y ; and Z is CR Z .

Metadata:
- Claim Count in Document: 87.0
- Percentile: 98.0
- Lexical Diversity: 1.2
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15166380', '12270135', '14465910', '16308739', '15521202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8168048641651308
- 35 USC 102 Novelty (BERT): 0.5164412611478889
- Combined Prediction Score: 0.7867685038634066
- Mean Citation Score: 326.669524
- Max Citation Score: 338.04504
- Similarity Product: 308.4930664945793

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test